Table 1 Demographic and clinical characteristics of migraine patients at baseline and in non-persistent and persistent study groups
Entire study population N = 7,866 (100%) | Non-persistent patients N = 5,414 (69.4%) | Persistent patients N = 2,390 (30.6%) | |
|---|---|---|---|
Age, years | |||
Mean (SD) | 48.2 (14.8) | 47.6 (14.7) | 48.8 (14.3) |
Age range, n (%) | |||
18—44 years | 3,296 (41.9%) | 2,343 (43.3%) | 949 (39.6%) |
45—64 years | 3,527 (44.8%) | 2,384 (44.1%) | 1,127 (47.1%) |
65—74 years | 713 (9.1%) | 479 (8.9%) | 223 (9.3%) |
≥ 75 years | 330 (4.2%) | 204 (3.8%) | 95 (4.0%) |
Gender (women), n (%) | 6,324 (80.4%) | 4,361 (80.6%) | 1,918 (80.3%) |
BMI, kg/m2 | |||
Mean (SD) | 27.8 (4.5) | 27.7 (4.5) | 27.9 (4.3) |
Time since diagnosis, yearsa | |||
Mean (SD) | 3.6 (1.9) | 3.6 (1.9) | 3.7 (1.9) |
Comorbidities per patient | |||
Mean (SD) | 1.6 (1.4) | 1.6 (1.4) | 1.6 (1.4) |
CCI | |||
Mean (SD) | 0.4 (0.9) | 0.4 (0.9) | 0.4 (0.9) |
Comorbidities, n (%) | |||
Generalized anxiety disorder | 2,827 (35.9%) | 1,968 (36.4%) | 813 (34.0%) |
Dyslipidaemia | 2,124 (27.0%) | 1,445 (26.7%) | 648 (27.1%) |
Arterial hypertension | 1,724 (21.9%) | 1,170 (21.6%) | 524 (21.9%) |
Obesity | 1,161 (14.8%) | 794 (14.7%) | 353 (14.8%) |
Depressive syndrome | 890 (11.3%) | 607 (11.2%) | 272 (11.4%) |
Asthma | 622 (7.9%) | 450 (8.3%) | 166 (6.9%) |
Malignant neoplasms | 620 (7.9%) | 439 (8.1%) | 168 (7.0%) |
Diabetes | 529 (6.7%) | 397 (7.3%) | 118 (4.9%) |
COPD | 220 (2.8%) | 154 (2.8%) | 63 (2.6%) |
Stroke | 170 (2.2%) | 112 (2.1%) | 55 (2.3%) |
Ischaemic heart disease | 115 (1.5%) | 69 (1.3%) | 41 (1.7%) |
Kidney failure | 121 (1.5%) | 85 (1.6%) | 30 (1.3%) |
Heart failure | 99 (1.3%) | 62 (1.1%) | 31 (1.3%) |
Other risk factors, n (%) | |||
Active smoking | 1,426 (18.1%) | 922 (17.0%) | 478 (20.0%) |